A detailed history of Paragon Private Wealth Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Paragon Private Wealth Management, LLC holds 4,207 shares of NVO stock, worth $368,743. This represents 0.25% of its overall portfolio holdings.

Number of Shares
4,207
Previous 4,170 0.89%
Holding current value
$368,743
Previous $595,000 15.97%
% of portfolio
0.25%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$119.07 - $145.42 $4,405 - $5,380
37 Added 0.89%
4,207 $500,000
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $134,490 - $161,013
1,096 Added 35.65%
4,170 $595,000
Q1 2024

May 13, 2024

BUY
$102.11 - $135.92 $50,238 - $66,872
492 Added 19.05%
3,074 $394,000
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $11,060 - $13,286
126 Added 5.13%
2,582 $267,000
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $223,348 - $490,070
2,456 New
2,456 $223,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Paragon Private Wealth Management, LLC Portfolio

Follow Paragon Private Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Private Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paragon Private Wealth Management, LLC with notifications on news.